Climb Bio (CLYM) Treasury Shares (2020 - 2026)
Climb Bio (CLYM) posted Treasury Shares of $207775.0 for Q1 2026, little changed on a QoQ basis from $207897.0 in Q4 2025, and down 77.13% year-over-year from $908543.0 in Q1 2025.
Climb Bio (CLYM) Treasury Shares (2020 - 2026) Analysis & Trends
Climb Bio's Treasury Shares history runs 7 years deep, the most recent figure standing at $207775.0 for Q1 2026.
- Quarterly Treasury Shares fell 77.13% year-over-year to $207775.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $207775.0 (down 77.13% YoY) and the FY2025 annual result came in at $207897.0, down 83.08% from the prior year.
- Treasury Shares was $207775.0 for Q1 2026 at Climb Bio, roughly flat from $207897.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $1.2 million in Q3 2024 and bottomed at $149975.0 in Q4 2023.
- A 5-year average of $461140.7 and a median of $219310.0 in 2022 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2022 — Treasury Shares plunged 98.43% — and 2024, when it jumped 719.39%.
- Climb Bio's Treasury Shares stood at $177495.0 in 2022, then fell by 15.5% to $149975.0 in 2023, then soared by 719.39% to $1.2 million in 2024, then plunged by 83.08% to $207897.0 in 2025, then decreased by 0.06% to $207775.0 in 2026.
- Business Quant data shows CLYM's Treasury Shares at $207775.0 in Q1 2026, $207897.0 in Q4 2025, and $207375.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Climb Bio | 870.33 Mn | 870.33 Mn | - | 207,775.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 207,775.00 |
| Mar 31, 2026 | 207,775.00 |
| Dec 31, 2025 | 207,897.00 |
| Dec 31, 2025 | 207,897.00 |
| Sep 30, 2025 | 207,375.00 |
| Sep 30, 2025 | 207,375.00 |
| Jun 30, 2025 | 627,710.00 |
| Jun 30, 2025 | 627,710.00 |
| Mar 31, 2025 | 908,543.00 |
| Mar 31, 2025 | 908,543.00 |
| Dec 31, 2024 | 1.23 Mn |
| Dec 31, 2024 | 1.23 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Sep 30, 2024 | 1.25 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 188,396.00 |
| Mar 31, 2024 | 188,396.00 |
| Dec 31, 2023 | 149,975.00 |
| Dec 31, 2023 | 149,975.00 |